Literature DB >> 12414963

Virus replication and cytokine production in dengue virus-infected human B lymphocytes.

Yu-Wen Lin1, Kuan-Ju Wang, Huan-Yao Lei, Yee-Shin Lin, Trai-Ming Yeh, Hsiao-Sheng Liu, Ching-Chuan Liu, Shun-Hua Chen.   

Abstract

Dengue virus (DV) replication, antibody-enhanced viral infection, and cytokine responses of human primary B lymphocytes (cells) were characterized and compared with those of monocytes. The presence of a replication template (negative-strand RNA intermediate), viral antigens including core and nonstructural proteins, and increasing amounts of virus with time postinfection indicated that DV actively replicated in B cells. Virus infection also induced B cells to produce interleukin-6 and tumor necrosis factor alpha, which have been previously implicated in virus pathogenesis. In addition, a heterologous antibody was able to enhance both virus and cytokine production in B cells. Furthermore, the levels of virus replication, antibody-enhanced virus replication, and cytokine responses observed in B cells were not statistically different from those in monocytes. These results suggest that B cells may play an important role in DV pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12414963      PMCID: PMC136880          DOI: 10.1128/jvi.76.23.12242-12249.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  Dengue virus infects human endothelial cells and induces IL-6 and IL-8 production.

Authors:  Y H Huang; H Y Lei; H S Liu; Y S Lin; C C Liu; T M Yeh
Journal:  Am J Trop Med Hyg       Date:  2000 Jul-Aug       Impact factor: 2.345

Review 2.  IgG Fc receptors.

Authors:  J V Ravetch; S Bolland
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

3.  Replication of dengue-2 virus in cultured human lymphoblastoid cells and subpopulations of human peripheral leukocytes.

Authors:  A N Theofilopoulos; W E Brandt; P K Russell; F T Dixon
Journal:  J Immunol       Date:  1976-09       Impact factor: 5.422

4.  IL-6 increases endothelial permeability in vitro.

Authors:  N Maruo; I Morita; M Shirao; S Murota
Journal:  Endocrinology       Date:  1992-08       Impact factor: 4.736

Review 5.  Immunopathogenesis of dengue virus infection.

Authors:  H Y Lei; T M Yeh; H S Liu; Y S Lin; S H Chen; C C Liu
Journal:  J Biomed Sci       Date:  2001-09       Impact factor: 8.410

6.  Generation of IgM anti-platelet autoantibody in dengue patients.

Authors:  C F Lin; H Y Lei; C C Liu; H S Liu; T M Yeh; S T Wang; T I Yang; F C Sheu; C F Kuo; Y S Lin
Journal:  J Med Virol       Date:  2001-02       Impact factor: 2.327

7.  Endothelial cell apoptosis induced by antibodies against dengue virus nonstructural protein 1 via production of nitric oxide.

Authors:  Chiou-Feng Lin; Huan-Yao Lei; Ai-Li Shiau; Hsiao-Sheng Liu; Trai-Ming Yeh; Shun-Hua Chen; Ching-Chuan Liu; Shu-Chen Chiu; Yee-Shin Lin
Journal:  J Immunol       Date:  2002-07-15       Impact factor: 5.422

8.  Isolation of dengue viruses from peripheral blood leukocytes of patients with hemorrhagic fever.

Authors:  R M Scott; A Nisalak; U Cheamudon; S Seridhoranakul; S Nimmannitya
Journal:  J Infect Dis       Date:  1980-01       Impact factor: 5.226

9.  Immunofluorescent staining of the surfaces of lymphocytes in suspension from patients with dengue hemorrhagic fever.

Authors:  S Boonpucknavig; N Bhamarapravati; S Nimmannitya; A Phalavadhtana; J Siripont
Journal:  Am J Pathol       Date:  1976-10       Impact factor: 4.307

10.  Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody.

Authors:  S B Halstead; E J O'Rourke
Journal:  J Exp Med       Date:  1977-07-01       Impact factor: 14.307

View more
  37 in total

1.  Toll-like receptor signaling controls reactivation of KSHV from latency.

Authors:  Sean M Gregory; John A West; Patrick J Dillon; Chelsey Hilscher; Dirk P Dittmer; Blossom Damania
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-29       Impact factor: 11.205

Review 2.  Elucidating the role of T cells in protection against and pathogenesis of dengue virus infections.

Authors:  Anuja Mathew; Elizabeth Townsley; Francis A Ennis
Journal:  Future Microbiol       Date:  2014       Impact factor: 3.165

Review 3.  Which Dengue Vaccine Approach Is the Most Promising, and Should We Be Concerned about Enhanced Disease after Vaccination? Questions Raised by the Development and Implementation of Dengue Vaccines: Example of the Sanofi Pasteur Tetravalent Dengue Vaccine.

Authors:  Bruno Guy
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-06-01       Impact factor: 10.005

4.  Human T Lymphocytes Are Permissive for Dengue Virus Replication.

Authors:  Guilherme F Silveira; Pryscilla F Wowk; Allan H D Cataneo; Paula F Dos Santos; Murilo Delgobo; Marco A Stimamiglio; Maria Lo Sarzi; Ana Paula F S Thomazelli; Ivete Conchon-Costa; Wander R Pavanelli; Lis R V Antonelli; André Báfica; Daniel S Mansur; Claudia N Duarte Dos Santos; Juliano Bordignon
Journal:  J Virol       Date:  2018-04-27       Impact factor: 5.103

Review 5.  Gammaherpesviruses and B Cells: A Relationship That Lasts a Lifetime.

Authors:  Kaitlin E Johnson; Vera L Tarakanova
Journal:  Viral Immunol       Date:  2020-01-08       Impact factor: 2.257

6.  The development, optimization and validation of an assay for high throughput antiviral drug screening against Dengue virus.

Authors:  Pulin Che; Lihua Wang; Qianjun Li
Journal:  Int J Clin Exp Med       Date:  2009-12-08

7.  An external loop region of domain III of dengue virus type 2 envelope protein is involved in serotype-specific binding to mosquito but not mammalian cells.

Authors:  Jan-Jong Hung; Meng-Ti Hsieh; Ming-Jer Young; Chuan-Liang Kao; Chwan-Chuen King; Wen Chang
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

8.  Viruses within the Flaviviridae decrease CD4 expression and inhibit HIV replication in human CD4+ cells.

Authors:  Jinhua Xiang; James H McLinden; Robert A Rydze; Qing Chang; Thomas M Kaufman; Donna Klinzman; Jack T Stapleton
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

9.  Primary human splenic macrophages, but not T or B cells, are the principal target cells for dengue virus infection in vitro.

Authors:  Shanley Blackley; Zhihua Kou; Huiyuan Chen; Matthew Quinn; Robert C Rose; Jacob J Schlesinger; Myra Coppage; Xia Jin
Journal:  J Virol       Date:  2007-10-10       Impact factor: 5.103

10.  Dengue virus infection and virus-specific HLA-A2 restricted immune responses in humanized NOD-scid IL2rgammanull mice.

Authors:  Smita Jaiswal; Todd Pearson; Heather Friberg; Leonard D Shultz; Dale L Greiner; Alan L Rothman; Anuja Mathew
Journal:  PLoS One       Date:  2009-10-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.